WealthPlan Investment Management LLC lifted its holdings in Danaher Co. (NYSE:DHR - Free Report) by 28.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,436 shares of the conglomerate's stock after buying an additional 5,842 shares during the quarter. WealthPlan Investment Management LLC's holdings in Danaher were worth $7,350,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. Fort Pitt Capital Group LLC raised its stake in Danaher by 3.2% in the 3rd quarter. Fort Pitt Capital Group LLC now owns 238,092 shares of the conglomerate's stock valued at $66,194,000 after purchasing an additional 7,421 shares during the last quarter. Good Life Advisors LLC acquired a new position in shares of Danaher in the 3rd quarter worth approximately $217,000. Oak Thistle LLC acquired a new stake in shares of Danaher during the second quarter worth $363,000. Harvest Portfolios Group Inc. boosted its holdings in shares of Danaher by 1.2% in the 3rd quarter. Harvest Portfolios Group Inc. now owns 202,263 shares of the conglomerate's stock valued at $56,233,000 after buying an additional 2,465 shares during the period. Finally, Diversified Trust Co grew its holdings in shares of Danaher by 75.4% during the second quarter. Diversified Trust Co now owns 4,360 shares of the conglomerate's stock valued at $1,090,000 after purchasing an additional 1,874 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Stifel Nicolaus boosted their price objective on Danaher from $250.00 to $265.00 and gave the stock a "hold" rating in a research report on Wednesday, October 23rd. Raymond James reduced their target price on Danaher from $310.00 to $300.00 and set an "outperform" rating for the company in a report on Wednesday, October 23rd. Robert W. Baird dropped their price target on Danaher from $278.00 to $277.00 and set an "outperform" rating on the stock in a research note on Wednesday, October 23rd. TD Cowen lifted their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. Finally, Bank of America upped their price target on shares of Danaher from $270.00 to $275.00 and gave the company a "neutral" rating in a research report on Wednesday, July 24th. Five analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $287.16.
Read Our Latest Analysis on DHR
Insider Buying and Selling
In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total transaction of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 11.10% of the company's stock.
Danaher Stock Performance
Shares of NYSE DHR traded down $2.55 during trading hours on Tuesday, hitting $240.70. 772,555 shares of the stock were exchanged, compared to its average volume of 2,738,425. Danaher Co. has a one year low of $193.75 and a one year high of $281.70. The company's 50 day moving average is $264.37 and its 200 day moving average is $260.82. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.37 and a quick ratio of 1.01. The firm has a market capitalization of $173.85 billion, a P/E ratio of 46.42, a P/E/G ratio of 4.51 and a beta of 0.85.
Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analysts' expectations of $5.59 billion. During the same quarter last year, the company earned $2.02 earnings per share. The firm's revenue was up 3.1% on a year-over-year basis. On average, research analysts expect that Danaher Co. will post 7.51 EPS for the current year.
Danaher Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were issued a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.45%. The ex-dividend date of this dividend was Friday, September 27th. Danaher's dividend payout ratio is currently 20.61%.
About Danaher
(
Free Report)
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Read More
Before you consider Danaher, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Danaher wasn't on the list.
While Danaher currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.